Primary hepatic amyloidosis: a mini literature review and five cases report
Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 5
Abstract
Primary hepatic amyloidosis (PHA) is characterized by abnormal deposition of monoclonal immunoglobulin light chains (AL) in the liver. This rare condition is frequently undiagnosed or misdiagnosed and can be associated with poor prognosis. At present, the precise pathogenesis is not fully understood. Despite that hepatomegaly and elevated alkaline phosphatase (ALP) are present in most patients with PHA, no specific clinical markers have been identified. Staining of hepatic tissues with Congo Red is often regarded as the “gold standard”. Pharmacological therapy should aim to rapidly reduce the supply of misfolded amyloidoge-nic AL. High-dose intravenous melphalan (HDM) and autologous stem cell transplantation (ASCT) appear to be the most appropriate therapy but controversies still exist.
Authors and Affiliations
Ya-Dong Wang, Cai-Yan Zhao, Hong-Zhu Yin
Keywords
Related Articles
- EP ID EP78198
- DOI -
- Views 122
- Downloads 0
Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy
Hepatic encephalopathy (HE) is a heterogeneous disease that develops as a result of serious liver disease, such as in fulminant hepatitis or cirrhosis, or a portosystemic shunt. It manifests as a spectrum of abnormalitie...
Adult live donor liver transplantation: routine, commonplace, standard care for end stage liver disease (we hope)
Impact of MELD score implementation on liver allocation: experience at a Brazilian center
Introduction. Model for end-stage liver disease (MELD) is an accurate predictor of mortality in patients with cirrhosis, and has been used on liver allocation in Brazil since 2006. However, its impact on organ allocation...
Clinical Characteristics and Complications of Pediatric Liver Biopsy: A Single Centre Experience
Introduction. Percutaneous liver biopsy (LB) is the gold standard method for evaluation and management of patients with liver disease. The purpose of this study was to characterize pediatric patients undergoing LB at Bri...
Budd Chiari syndrome without evidence for thrombosis. Is it still a Budd Chiari ?